CVS Health Corporation (CVS)
NYSE: CVS
· Real-Time Price · USD
75.78
1.17 (1.57%)
At close: Sep 26, 2025, 3:59 PM
75.49
-0.38%
After-hours: Sep 26, 2025, 07:49 PM EDT
CVS Health Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate And Other Segment Revenue | 96M | 52.51B | 56.24B | 54.66B | 50.98B | 48.4B | 59.69B | 56.2B | 25.11B | 24.35B | 21.44B | 21B | 21.26B | 21.63B | 19.2B | 18.98B | 18.98B | 18.96B | 17.61B | 43.06B | 41.77B | 41.87B | 44.16B | 42.55B | 40.67B | 4.8B | 42.83B | 41.77B | 40.95B | 39.3B |
| Corporate And Other Segment Revenue Growth | -99.82% | -6.63% | +2.89% | +7.22% | +5.34% | -18.92% | +6.22% | +123.83% | +3.10% | +13.60% | +2.06% | -1.21% | -1.72% | +12.63% | +1.16% | +0.01% | +0.12% | +7.64% | -59.09% | +3.08% | -0.23% | -5.17% | +3.77% | +4.63% | +747.43% | -88.79% | +2.53% | +2.01% | +4.18% | n/a |
| Pharmacy Revenue Revenue | 55.35B | 3.5B | 4.13B | 4.1B | 3.91B | 3.83B | 2.92B | 3.26B | 2.85B | 2.5B | 2.01B | 2B | 2.17B | 2.22B | 2.27B | 2.17B | 2.16B | 2.25B | 2.06B | 1.87B | 1.8B | 1.87B | 5.13B | 4.61B | 4.88B | 38.52B | 5.07B | 4.56B | 4.71B | 4.73B |
| Pharmacy Revenue Revenue Growth | +1482.30% | -15.32% | +0.81% | +4.75% | +2.27% | +31.13% | -10.55% | +14.50% | +14.15% | +24.31% | +0.40% | -7.80% | -2.52% | -2.07% | +4.56% | +0.65% | -3.92% | +9.24% | +10.06% | +3.61% | -3.74% | -63.52% | +11.27% | -5.35% | -87.35% | +660.59% | +11.15% | -3.19% | -0.40% | n/a |
| Product and Service, Other Revenue | 3.52B | 5.24B | 5.67B | 5.2B | 5.28B | 5.37B | 5.86B | 5.37B | 55.06B | 52.5B | 53.93B | 52.38B | 51.33B | 47.49B | 48.7B | 47.03B | 45.93B | 42.95B | 44.58B | 4.74B | 4.65B | 5.21B | 15.51B | 15.54B | 15.79B | 16.28B | 8.18B | 944M | 1.05B | 1.66B |
| Product and Service, Other Revenue Growth | -32.94% | -7.61% | +9.22% | -1.61% | -1.66% | -8.38% | +9.12% | -90.25% | +4.88% | -2.65% | +2.97% | +2.04% | +8.08% | -2.49% | +3.55% | +2.40% | +6.94% | -3.65% | +840.53% | +1.87% | -10.66% | -66.42% | -0.19% | -1.60% | -3.02% | +98.95% | +766.95% | -10.44% | -36.58% | n/a |
| Front Store Revenue Revenue | 5.37B | 32.82B | 30.91B | 30.93B | 30.67B | 30.39B | 25.07B | 24.66B | 5.63B | 5.6B | 6.15B | 5.58B | 5.74B | 5.31B | 6.06B | 5.36B | 5.25B | 4.64B | 5.05B | 17.18B | 16.93B | 17.64B | 1.88B | 1.84B | 1.8B | 1.79B | n/a | n/a | n/a | n/a |
| Front Store Revenue Revenue Growth | -83.64% | +6.17% | -0.04% | +0.84% | +0.91% | +21.20% | +1.70% | +338.04% | +0.57% | -8.99% | +10.20% | -2.70% | +7.96% | -12.33% | +13.08% | +2.00% | +13.18% | -8.15% | -70.59% | +1.51% | -4.04% | +836.31% | +2.28% | +2.11% | +0.67% | n/a | n/a | n/a | n/a | n/a |
| Premiums Revenue | 34.2B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Premiums Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |